07.10.2013 - Novartis said it had overhauled management operations and sanctioned key staff in Japan after a scandal involving research into its Diovan blood pressure drug in the country. The...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)